DrugDashboards

Labetalol Hydrochloride

Labetalol Hydrochloride · LABETALOL HYDROCHLORIDE 400 mg/1 · Tablet · Oral · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

NDC 23155-0726-01 · 100 TABLET in 1 BOTTLE · ANDA · View full market →

The short version

6 companies supply this market — a reasonable cushion if one runs into trouble. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$1.00$2.00Sep 2026Sep 2026$1.52
1 price point · per EASource: CMS NADAC

Estimated fill cost

#30 count
$45.54
#90 count
$136.63

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Supply fragility

0Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for labetalol hydrochloride (oral solid) in the next 90 days

sole-source market · price up 2% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA074787
TE code
AB
Approval date
Aug 3, 1998
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Labetalol Hydrochloride (Tablet)

LabelerStrengthFirst seenLast seen
BluePoint LaboratoriesLABETALOL HYDROCHLORIDE 100 mg/1Jul 15, 2026Sep 2, 2026
BluePoint LaboratoriesLABETALOL HYDROCHLORIDE 200 mg/1Jul 15, 2026Sep 2, 2026
BluePoint LaboratoriesLABETALOL HYDROCHLORIDE 300 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCLABETALOL HYDROCHLORIDE 200 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCLABETALOL HYDROCHLORIDE 100 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCLABETALOL HYDROCHLORIDE 300 mg/1Jul 15, 2026Sep 2, 2026
Coupler LLCLABETALOL HYDROCHLORIDE 100 mg/1Aug 26, 2026Sep 2, 2026
Epic Pharma, LLCLABETALOL HYDROCHLORIDE 100 mg/1Jul 15, 2026Sep 2, 2026
Epic Pharma, LLCLABETALOL HYDROCHLORIDE 200 mg/1Jul 15, 2026Sep 2, 2026
Epic Pharma, LLCLABETALOL HYDROCHLORIDE 300 mg/1Jul 15, 2026Sep 2, 2026
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.LABETALOL HYDROCHLORIDE 200 mg/1Jul 15, 2026Sep 2, 2026
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.LABETALOL HYDROCHLORIDE 100 mg/1Jul 15, 2026Sep 2, 2026
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.LABETALOL HYDROCHLORIDE 300 mg/1Jul 15, 2026Sep 2, 2026
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.LABETALOL HYDROCHLORIDE 400 mg/1Jul 15, 2026Sep 2, 2026
NorthStar Rx LLCLABETALOL HYDROCHLORIDE 100 mg/1Jul 15, 2026Sep 2, 2026
NorthStar Rx LLCLABETALOL HYDROCHLORIDE 300 mg/1Jul 15, 2026Sep 2, 2026
NorthStar Rx LLCLABETALOL HYDROCHLORIDE 200 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Labetalol Hydrochloride — NDC 23155-0726-01," retrieved September 3, 2026, https://drugdashboards.com/drug/23155072601.

Free to cite with attribution — see how the data is put together.